Skip to main content

Agar Advisory

Future Patients: Why Procurement Matters in Emerging Life Sciences

Explores how procurement can become a strategic enabler of patient-centricity by translating future patient needs into supplier strategies, operating models and resilient ecosystems from the earliest stages of company growth. Read article

The Key Role of Clinical Supply Teams in Patient Centricity Efforts

Examines how clinical supply, procurement and supply chain decisions directly influence patient experience, trial continuity and treatment access, arguing that patient-centric clinical research requires patient-focused operational decision-making. Read article

The Future of Biologistics

Looks ahead to the next two decades of pharmaceutical logistics, exploring how biologics, AI, smart packaging, decentralised manufacturing and sustainable supply chains will reshape the delivery of advanced therapies. Read article.

You Just Secured $50 Million. Now On To The Hard Part: Clinical Trials

Discusses the procurement and supplier management challenges facing newly funded biotech companies, with practical guidance on selecting CROs, negotiating contracts and managing the largest area of early-stage expenditure. Read article

Proactive Procurement Strategies for Biotech with Tom Wells

A discussion on why procurement should be viewed as a strategic capability in emerging biotech, covering supplier selection, investor confidence, risk management and practical approaches that support sustainable growth. Listen to the podcast